Investor Deck gives a good summary of EX1 technology and where the Company sits within the world players. Video on their website is a must listen imo!! Not selling any of mine anytime soon!!
Page 15 of the investor deck:
As yet there are no known clinical trials underway in regenerative medicine withproprietary pharma-grade purified adult stem cell derived exosomes
Point four on page 10:
Aiming to commence first-in-human initial small-scaleclinical studies of autologous Plexaris in wound healingtreating by mid CY ’19
